DUOBODY
LIVE

Serial Number

79135579

Owner

Genmab A/S

Attorney

Max Vern

Filing Date

Jun 6, 2013

Add to watchlist:

No watchlists yet
View on USPTO

DUOBODY Trademark

Serial Number: 79135579 • Registration: 4582290

DUOBODY is a trademark filed by Genmab A/S on June 6, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Genmab A/S (46 trademarks)

Carl Jacobsens Vej 30

Entity Type: 98

Trademark Details

Filing Date

June 6, 2013

Registration Date

August 12, 2014

Published for Opposition

May 27, 2014

Cancellation Date

March 6, 2026

Goods & Services

[ Chemical, ] biochemical, biological and biotechnological preparations, especially antibodies, and bi and multi specific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these, all for vitro and in vivo scientific and industrial research and development with regard to diseases

Pharmaceutical [ and veterinary ] preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to treatment of cancer, infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases

Medical, scientific and biological research, especially research into antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies, bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these

Legal services in the form of patent exploitation and licensing of intellectual property in the field of medicines

Filing History

CANCELLED SECTION 71
Mar 6, 2026 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Mar 21, 2025 NREP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 5, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 5, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 5, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 5, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 5, 2024 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 15, 2023 ADCH
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 12, 2023 REM4
INTERNATIONAL REGISTRATION RENEWED
Apr 7, 2023 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Dec 25, 2021 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 14, 2021 INPS
INVALIDATION PROCESSED
Nov 14, 2021 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 24, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 24, 2021 NA71
REGISTERED-SEC.71 ACCEPTED
Feb 24, 2021 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2021 APRE
TEAS SECTION 71 RECEIVED
Feb 3, 2021 ES71
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 26, 2017 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Sep 8, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 20, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 9, 2017 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 9, 2017 ADCH
REGISTERED - SEC. 7 REQUEST ABANDONED
Jul 27, 2016 PRA7
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 27, 2015 FICS
FINAL DISPOSITION PROCESSED
Jan 27, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 12, 2014 FICR
POST REGISTRATION ACTION MAILED - SEC. 7
Sep 22, 2014 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 14, 2014 APRE
TEAS SECTION 7 REQUEST RECEIVED
Sep 4, 2014 ES7R
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2014 R.PR
PUBLISHED FOR OPPOSITION
May 27, 2014 PUBO
NOTIFICATION PROCESSED BY IB
May 23, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 7, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 7, 2014 OP2R
NOTICE OF PUBLICATION
May 7, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 24, 2014 PREV
ASSIGNED TO LIE
Apr 24, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2014 CNSA
EXAMINERS AMENDMENT MAILED
Apr 2, 2014 CNEA
EXAMINER'S AMENDMENT ENTERED
Apr 2, 2014 XAEC
EXAMINERS AMENDMENT -WRITTEN
Apr 2, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2014 TROA
REFUSAL PROCESSED BY IB
Oct 16, 2013 RFNT
APPLICATION FILING RECEIPT MAILED
Sep 24, 2013 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 23, 2013 RFCS
REFUSAL PROCESSED BY MPU
Sep 23, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 21, 2013 RFCR
NON-FINAL ACTION WRITTEN
Sep 20, 2013 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 13, 2013 REPR